Canada markets close in 2 hours 59 minutes

NOXXON Pharma N.V. (ALNOX.PA)

Paris - Paris Delayed Price. Currency in EUR
Add to watchlist
0.0900-0.0001 (-0.11%)
At close: 05:27PM CEST
Full screen
Previous Close0.0901
Open0.0901
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0866 - 0.0901
52 Week Range0.0842 - 0.5200
Volume186,511
Avg. Volume578,899
Market Cap6.706M
Beta (5Y Monthly)1.95
PE Ratio (TTM)N/A
EPS (TTM)-0.2190
Earnings DateApr 28, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est7.24
  • Business Wire

    NOXXON Announces Results of the Extraordinary General Meeting of Shareholders

    BERLIN, May 16, 2022--Regulatory News: NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX) (Paris:ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME), announced today that the extraordinary general meeting of shareholders held on Monday, May 16, 2022 at the offices of Freshfields Bruckhaus Deringer LLP, Strawinskylaan 10, 1077 XZ in Amsterdam, the Netherlands approved the proposed share consolidation to be implemented by way of parti

  • Business Wire

    NOXXON Appoints Leading Brain Cancer Experts to Scientific Advisory Board

    BERLIN, May 11, 2022--Regulatory News: NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX) (Paris:ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME), announced today the appointment of two leading brain cancer experts to its Scientific Advisory Board (SAB). Prof. Monika Hegi and Dr. Michael Lim and will complement the current SAB and provide strategic and scientific counsel to NOXXON’s lead NOX-A12 program in brain cancer (glioblast

  • Business Wire

    Noxxon Reports 2021 Financial Results

    BERLIN, April 22, 2022--Regulatory News: NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX) (Paris:ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME), announced today its financial results for the fiscal year ending December 31, 2021.